Vericel (VCEL) Total Debt (2010 - 2018)
Vericel (VCEL) posted Total Debt of $17.3 million for Q3 2018, little changed sequentially from $17.3 million in Q2 2018, and up 73.55% YoY from $10.0 million in Q3 2017.
Vericel (VCEL) Total Debt (2010 - 2018) Analysis & Trends
Vericel has reported Total Debt for 9 years, with the latest figure at $17.3 million in Q3 2018.
- Quarterly Total Debt rose 73.55% year-over-year to $17.3 million in Q3 2018, while the trailing twelve-month figure through Sep 2018 was $17.3 million (up 73.55% YoY) and the FY2017 annual result came in at $17.2 million, up 2025.52% from the prior year.
- Total Debt steadied at $17.3 million in Q3 2018 per VCEL's latest filing, from $17.3 million in the prior quarter.
- Over five years, Total Debt peaked at $17.3 million in Q3 2018 and troughed at $2000.0 in Q1 2014.
- A 5-year average of $5.8 million and a median of $1.7 million in 2014 frame the typical range for Total Debt.
- The sharpest annual moves came in 2015 and 2017: Total Debt sank 96.36% in 2015, then soared 19423.08% in 2017.
- Over 5 years, Total Debt stood at $457000.0 in 2014, then tumbled by 84.46% to $71000.0 in 2015, then surged by 1042.25% to $811000.0 in 2016, then surged by 2025.52% to $17.2 million in 2017, then gained by 0.24% to $17.3 million in 2018.
- According to Business Quant data, Total Debt over the past three periods registered $17.3 million, $17.3 million, and $17.2 million for Q3 2018, Q2 2018, and Q1 2018 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.07 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 9.34 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 546.77 Mn |
| 10 | Vericel | 2.26 Bn | 2.10 Bn | 56.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 17.28 Mn |
| Jun 30, 2018 | 17.26 Mn |
| Mar 31, 2018 | 17.25 Mn |
| Dec 31, 2017 | 17.24 Mn |
| Sep 30, 2017 | 9.96 Mn |
| Jun 30, 2017 | 10.15 Mn |
| Mar 31, 2017 | 10.13 Mn |
| Dec 31, 2016 | 811,000.00 |
| Sep 30, 2016 | 5.61 Mn |
| Jun 30, 2016 | 52,000.00 |
| Mar 31, 2016 | 62,000.00 |
| Dec 31, 2015 | 71,000.00 |
| Sep 30, 2015 | 81,000.00 |
| Jun 30, 2015 | 91,000.00 |
| Mar 31, 2015 | 100,000.00 |
| Dec 31, 2014 | 457,000.00 |
| Sep 30, 2014 | 153,000.00 |
| Jun 30, 2014 | 2.50 Mn |
| Mar 31, 2014 | 2,000.00 |
| Dec 31, 2013 | 6,000.00 |